News from Zyme and the companies we work with.
CN Bio licenses human gut microbiome modelling tool from MIT and Northeastern University
Enables accurate modelling of the human colon and the mucosal barrier Provides new insights to the relationship between human microbiome and effect on human health Model to be integrated into [...]
ERS Genomics and Japan SLC sign CRISPR/Cas9 license agreement
Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models Dublin, Ireland & Shizuoka, Japan, 27 July 2021: ERS Genomics Limited, which was formed to [...]
Metrion Biosciences appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development
Appointment supports international growth within ion channel contract research and drug discovery Cambridge, UK, 26 July 2021: Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery [...]
Orbit Discovery announces $7.6 million funding to accelerate growth in peptide discovery business
Oxford, United Kingdom, 20 July, 2021: Orbit Discovery Ltd., (“Orbit”), a privately held biopharmaceutical company focused on discovering candidate peptide therapeutics harnessing proprietary affinity and cell-based functional screening platforms, today [...]
Owlstone Medical Publishes Data on the Use of Face Mask Filters to Capture Viral Particles for SARS-CoV-2 Detection
Study published in Nature Scientific Reports demonstrates embedded filters capture virus particles with limits of detection of ~10 copies per filter Data consistent with findings that COVID is most infectious [...]
Lonza and CN Bio Announce Distribution Agreement Providing Prevalidated Hepatocytes for Use on Innovative Organ-on-a-chip Range
Through a new distribution agreement, Lonza will supply a selection of cells to be prequalified for use in CN Bio’s innovative PhysioMimixTM Organ-On-a-Chip (OOC) range of Single- and Multi-organ Microphysiological [...]
Mologic to become a ‘Social Enterprise’ after acquisition by social impact funders and investors
Social Enterprise set up by group of philanthropic funds led by George Soros’ Economic Development Fund, with support from Bill & Melinda Gates Foundation New venture aims to expand affordable [...]
Dotmatics Announces Support for AWS for Health Initiative
Bishop’s Stortford, UK, 16 July 2021: Dotmatics, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, announced [...]
H.E.L Group strengthens operations in North America
Extending support for US customers with the establishment of West Coast and Central Region hubs London, UK, 15 July 2021: H.E.L Group (H.E.L), a global developer and manufacturer of innovative [...]
Bio-Rad Launches Its Reliance SARS-CoV-2/FluA/FluB RT-PCR Assay Kit in Europe
HERCULES, Calif.–July 14, 2021–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Reliance SARS-CoV-2/FluA/FluB™ RT-PCR [...]
Avacta’s Diagnostic Division Achieves ISO 13485 Certification
Cambridge and Wetherby, UK, 14 July 2021: Avacta Group plc (AIM: AVCT), the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, is pleased [...]
Gyros Protein Technologies and Cygnus Technologies expand collaboration to support improved bioprocess impurity analytics, and introduce HEK 293 HCP Assay Reagent Set for Gyrolab
Collaboration is poised to deliver a range of ready-to-use bioprocess impurity reagent sets optimized for use with the Gyrolab platform New reagent set effectively detects host cell impurities from HEK [...]
